Related Experiment Videos
Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation
Andrei Kuzmichev1, Raphael Margueron, Alejandro Vaquero
1Howard Hughes Medical Institute, Division of Nucleic Acids Enzymology, Department of Biochemistry, Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
Summary
Altered histone modification enzymes like Ezh2 can drive prostate cancer by forming new Polycomb Repressive Complexes (PRCs). These complexes, including the novel PRC4, may reprogram gene expression in cancer.
Area of Science:
- Epigenetics and Molecular Biology
- Cancer Research
- Chromatin Biology
Background:
- Epigenetic modifications, particularly histone alterations, significantly impact gene expression.
- Polycomb Repressive Complexes (PRC2/3) regulate chromatin structure, and their components, including Ezh2 (enhancer of zeste homolog 2), are implicated in cancer.
- Elevated Ezh2 levels are observed during prostate cancer progression.
Purpose of the Study:
- To investigate the role of Ezh2 and its associated complexes in prostate cancer progression.
- To identify novel Polycomb Repressive Complexes (PRCs) formed under conditions of Ezh2 overexpression.
- To explore the substrate specificities and potential functions of these newly identified complexes in regulating gene expression.
Main Methods:
- Analysis of Ezh2 and other PRC2/3 component levels in prostate cancer.
- Overexpression of Ezh2 in tissue culture to induce the formation of new PRC complexes.
- Characterization of the composition and histone substrate specificities of distinct PRC complexes, including the novel PRC4.
Main Results:
- Ezh2 and other PRC2/3 components are elevated in cancer cells.
- Ezh2 overexpression leads to the formation of a novel PRC complex, PRC4, containing SirT1 (sirtuin 1) and Eed2 (embryonic ectoderm development 2).
- Eed2 expression is specific to cancer cells and undifferentiated embryonic stem cells.
- Different PRC complexes exhibit distinct histone substrate specificities.
Conclusions:
- The formation of transformation-specific PRC complexes, such as PRC4, plays a significant role in cancer.
- These novel complexes may reprogram gene expression patterns by altering chromatin structure.
- Understanding these epigenetic mechanisms is crucial for developing targeted cancer therapies.